UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.56 -1.07 (-1.29%) GOLD FUTURES
2,302.90 -54.80 (-2.32%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
47,834.83 -2,608.49 (-5.17%)
C4 Therapeutics, Inc. (CCCC)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 6.32 |
| Open | 6.22 |
| Bid | 6.26 x 200 |
| Ask | 6.32 x 400 |
| Day's range | 6.17 - 6.38 |
| 52-week range | 1.06 - 11.88 |
| Volume | |
| Avg. volume | 2,426,433 |
| Market cap | 432.184M |
| Beta (5Y monthly) | 3.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Here’s Why Meridian Small Cap Growth Fund Trimmed C4 Therapeutics (CCCC)
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Small Cap Growth Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. During the final months of the year, optimism prevailed due to news of reducing inflation and the potential for lower interest rates in 2024. The fund returned 13.64% (net) […]
- Simply Wall St.
New Forecasts: Here's What Analysts Think The Future Holds For C4 Therapeutics, Inc. (NASDAQ:CCCC)
C4 Therapeutics, Inc. ( NASDAQ:CCCC ) shareholders will have a reason to smile today, with the analysts making...
- Simply Wall St.
C4 Therapeutics Full Year 2023 Earnings: Misses Expectations
C4 Therapeutics ( NASDAQ:CCCC ) Full Year 2023 Results Key Financial Results Revenue: US$20.8m (down 33% from FY 2022...
© 2024 Yahoo. All rights reserved.